CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) Stock Fundamental Analysis

NYSE:FCRX • US2256552082

24.86 USD
-0.38 (-1.51%)
Last: Feb 27, 2026, 08:04 PM
Fundamental Rating

2

FCRX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. FCRX may be in some trouble as it scores bad on both profitability and health. FCRX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • FCRX had positive earnings in the past year.
  • In the past year FCRX had a positive cash flow from operations.
  • Of the past 5 years FCRX 4 years were profitable.
  • In multiple years FCRX reported negative operating cash flow during the last 5 years.
FCRX Yearly Net Income VS EBIT VS OCF VS FCFFCRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

  • FCRX's Return On Assets of 2.21% is in line compared to the rest of the industry. FCRX outperforms 43.70% of its industry peers.
  • FCRX has a Return On Equity of 5.04%. This is in the lower half of the industry: FCRX underperforms 60.08% of its industry peers.
  • FCRX has a Return On Invested Capital of 3.58%. This is comparable to the rest of the industry: FCRX outperforms 50.84% of its industry peers.
  • FCRX had an Average Return On Invested Capital over the past 3 years of 4.11%. This is below the industry average of 7.32%.
Industry RankSector Rank
ROA 2.21%
ROE 5.04%
ROIC 3.58%
ROA(3y)3.6%
ROA(5y)4.46%
ROE(3y)7.92%
ROE(5y)9.27%
ROIC(3y)4.11%
ROIC(5y)3.85%
FCRX Yearly ROA, ROE, ROICFCRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • FCRX has a Profit Margin (20.83%) which is comparable to the rest of the industry.
  • FCRX's Profit Margin has declined in the last couple of years.
  • FCRX's Operating Margin of 41.76% is fine compared to the rest of the industry. FCRX outperforms 74.79% of its industry peers.
  • In the last couple of years the Operating Margin of FCRX has declined.
  • FCRX's Gross Margin of 44.06% is in line compared to the rest of the industry. FCRX outperforms 47.90% of its industry peers.
  • FCRX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 41.76%
PM (TTM) 20.83%
GM 44.06%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
FCRX Yearly Profit, Operating, Gross MarginsFCRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

  • There is no outstanding debt for FCRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FCRX Yearly Shares OutstandingFCRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
FCRX Yearly Total Debt VS Total AssetsFCRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • FCRX has an Altman-Z score of 0.63. This is a bad value and indicates that FCRX is not financially healthy and even has some risk of bankruptcy.
  • FCRX has a Altman-Z score (0.63) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of FCRX is 17.80, which is on the high side as it means it would take FCRX, 17.80 years of fcf income to pay off all of its debts.
  • FCRX has a Debt to FCF ratio of 17.80. This is comparable to the rest of the industry: FCRX outperforms 56.72% of its industry peers.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that FCRX has dependencies on debt financing.
  • FCRX has a worse Debt to Equity ratio (1.23) than 61.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 17.8
Altman-Z 0.63
ROIC/WACCN/A
WACCN/A
FCRX Yearly LT Debt VS Equity VS FCFFCRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • FCRX has a Current Ratio of 0.31. This is a bad value and indicates that FCRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FCRX has a worse Current ratio (0.31) than 79.83% of its industry peers.
  • FCRX has a Quick Ratio of 0.31. This is a bad value and indicates that FCRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of FCRX (0.31) is worse than 79.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
FCRX Yearly Current Assets VS Current LiabilitesFCRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

  • The earnings per share for FCRX have decreased strongly by -28.35% in the last year.
  • FCRX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.22% yearly.
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.07%

3.2 Future

  • Based on estimates for the next years, FCRX will show a decrease in Earnings Per Share. The EPS will decrease by -9.13% on average per year.
  • The Revenue is expected to decrease by -4.31% on average over the next years.
EPS Next Y-9.61%
EPS Next 2Y-9.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.18%
Revenue Next 2Y-4.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
FCRX Yearly Revenue VS EstimatesFCRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
FCRX Yearly EPS VS EstimatesFCRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.66, the valuation of FCRX can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of FCRX is on the same level as its industry peers.
  • FCRX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 15.11, the valuation of FCRX can be described as correct.
  • FCRX's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of FCRX to the average of the S&P500 Index (28.05), we can say FCRX is valued slightly cheaper.
Industry RankSector Rank
PE 13.66
Fwd PE 15.11
FCRX Price Earnings VS Forward Price EarningsFCRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, FCRX is valued a bit cheaper than the industry average as 63.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.7
EV/EBITDA N/A
FCRX Per share dataFCRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as FCRX's earnings are expected to decrease with -9.13% in the coming years.
PEG (NY)N/A
PEG (5Y)61.74
EPS Next 2Y-9.13%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • FCRX has a Yearly Dividend Yield of 13.27%, which is a nice return.
  • FCRX's Dividend Yield is rather good when compared to the industry average which is at 6.42. FCRX pays more dividend than 81.51% of the companies in the same industry.
  • FCRX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 13.27%

5.2 History

  • The dividend of FCRX is nicely growing with an annual growth rate of 11.57%!
  • FCRX has been paying a dividend for over 5 years, so it has already some track record.
  • FCRX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.57%
Div Incr Years0
Div Non Decr Years3
FCRX Yearly Dividends per shareFCRX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • FCRX pays out 195.52% of its income as dividend. This is not a sustainable payout ratio.
  • FCRX's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP195.52%
EPS Next 2Y-9.13%
EPS Next 3YN/A
FCRX Yearly Income VS Free CF VS DividendFCRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M
FCRX Dividend Payout.FCRX Dividend Payout, showing the Payout Ratio.FCRX Dividend Payout.PayoutRetained Earnings

CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26

NYSE:FCRX (2/27/2026, 8:04:00 PM)

24.86

-0.38 (-1.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-25
Earnings (Next)05-12
Inst Owners55.8%
Inst Owner ChangeN/A
Ins Owners1.16%
Ins Owner ChangeN/A
Market Cap919.57M
Revenue(TTM)N/A
Net Income(TTM)36.01M
Analysts84.62
Price Target31.15 (25.3%)
Short Float %0%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 13.27%
Yearly Dividend2.03
Dividend Growth(5Y)11.57%
DP195.52%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-27
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.82%
Min EPS beat(2)-4.13%
Max EPS beat(2)-3.5%
EPS beat(4)0
Avg EPS beat(4)-6.96%
Min EPS beat(4)-15.91%
Max EPS beat(4)-3.5%
EPS beat(8)3
Avg EPS beat(8)1.43%
EPS beat(12)7
Avg EPS beat(12)2.92%
EPS beat(16)9
Avg EPS beat(16)1.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)-0.86%
Revenue beat(8)4
Avg Revenue beat(8)-1.09%
Revenue beat(12)7
Avg Revenue beat(12)0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.14%
PT rev (1m)12.25%
PT rev (3m)6.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 13.66
Fwd PE 15.11
P/S 5.32
P/FCF 18.7
P/OCF 18.7
P/B 1.29
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)1.82
EY7.32%
EPS(NY)1.65
Fwd EY6.62%
FCF(TTM)1.33
FCFY5.35%
OCF(TTM)1.33
OCFY5.35%
SpS4.67
BVpS19.3
TBVpS19.3
PEG (NY)N/A
PEG (5Y)61.74
Graham Number28.12
Profitability
Industry RankSector Rank
ROA 2.21%
ROE 5.04%
ROCE 4.54%
ROIC 3.58%
ROICexc 3.6%
ROICexgc 3.6%
OM 41.76%
PM (TTM) 20.83%
GM 44.06%
FCFM 28.45%
ROA(3y)3.6%
ROA(5y)4.46%
ROE(3y)7.92%
ROE(5y)9.27%
ROIC(3y)4.11%
ROIC(5y)3.85%
ROICexc(3y)4.13%
ROICexc(5y)3.88%
ROICexgc(3y)4.16%
ROICexgc(5y)3.9%
ROCE(3y)5.2%
ROCE(5y)4.87%
ROICexgc growth 3Y12.5%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y12.44%
ROICexc growth 5Y5.15%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 17.8
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.29
Cash Conversion N/A
Profit Quality 136.59%
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 0.63
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.35%
EPS 3Y1.51%
EPS 5Y0.22%
EPS Q2Q%-18.18%
EPS Next Y-9.61%
EPS Next 2Y-9.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.07%
Revenue Next Year-6.18%
Revenue Next 2Y-4.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.53%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.59%
OCF growth 3YN/A
OCF growth 5YN/A

CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 / FCRX FAQ

Can you provide the ChartMill fundamental rating for CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26?

ChartMill assigns a fundamental rating of 2 / 10 to FCRX.


Can you provide the valuation status for CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26?

ChartMill assigns a valuation rating of 3 / 10 to CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX). This can be considered as Overvalued.


How profitable is CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) stock?

CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) has a profitability rating of 3 / 10.


What are the PE and PB ratios of CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) stock?

The Price/Earnings (PE) ratio for CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) is 13.66 and the Price/Book (PB) ratio is 1.29.


What is the financial health of CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) stock?

The financial health rating of CRESCENT CAPITAL BDC INC - CCABDC 5 05/25/26 (FCRX) is 1 / 10.